PRESTIGE BIOPHARMA LIMITED KDR financial statements, including revenue, expenses, profit, and loss

The total revenue of 950210 for the last quarter is 643.03 M KRW, and it's 436.33% higher compared to the previous quarter. The net income of Q3 24 is -1.45 B KRW.